News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,884 Results
Type
Article (46782)
Company Profile (640)
Press Release (671462)
Multimedia
Podcasts (99)
Webinars (13)
Section
Business (211664)
Career Advice (2848)
Deals (37093)
Drug Delivery (114)
Drug Development (82586)
Employer Resources (177)
FDA (16381)
Job Trends (15896)
News (356704)
Policy (33227)
Tag
Academia (2207)
Academic (2)
Accelerated approval (5)
Adcomms (19)
Allergies (92)
Alliances (51835)
ALS (104)
Alzheimer's disease (1421)
Antibody-drug conjugate (ADC) (153)
Approvals (16354)
Artificial intelligence (295)
Autoimmune disease (29)
Automation (17)
Bankruptcy (382)
Best Places to Work (11895)
BIOSECURE Act (22)
Biosimilars (110)
Biotechnology (438)
Bladder cancer (83)
Brain cancer (26)
Breast cancer (295)
Cancer (2362)
Cardiovascular disease (197)
Career advice (2397)
Career pathing (34)
CAR-T (166)
Cell therapy (477)
Cervical cancer (21)
Clinical research (67191)
Collaboration (906)
Company closure (2)
Compensation (571)
Complete response letters (28)
COVID-19 (2684)
CRISPR (46)
C-suite (275)
Cystic fibrosis (104)
Data (2348)
Decentralized trials (2)
Denatured (27)
Depression (54)
Diabetes (283)
Diagnostics (6634)
Digital health (20)
Diversity (5)
Diversity, equity & inclusion (41)
Drug discovery (124)
Drug pricing (120)
Drug shortages (30)
Duchenne muscular dystrophy (101)
Earnings (88575)
Editorial (47)
Employer branding (24)
Employer resources (153)
Events (119142)
Executive appointments (783)
FDA (17763)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (811)
Gene editing (120)
Generative AI (29)
Gene therapy (348)
GLP-1 (809)
Government (4253)
Grass and pollen (6)
Guidances (158)
Healthcare (18758)
Huntington's disease (24)
IgA nephropathy (31)
Immunology and inflammation (148)
Indications (30)
Infectious disease (2835)
Inflammatory bowel disease (152)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (101)
Interviews (546)
IPO (17399)
IRA (48)
Job creations (4470)
Job search strategy (1986)
Kidney cancer (11)
Labor market (41)
Layoffs (561)
Leadership (24)
Legal (8264)
Liver cancer (77)
Lung cancer (329)
Lymphoma (149)
Machine learning (7)
Management (63)
Manufacturing (360)
MASH (81)
Medical device (14048)
Medtech (14053)
Mergers & acquisitions (20276)
Metabolic disorders (758)
Multiple sclerosis (87)
NASH (19)
Neurodegenerative disease (109)
Neuropsychiatric disorders (32)
Neuroscience (2027)
NextGen: Class of 2025 (6895)
Non-profit (3982)
Now hiring (41)
Obesity (405)
Opinion (268)
Ovarian cancer (80)
Pain (101)
Pancreatic cancer (90)
Parkinson's disease (160)
Partnered (23)
Patents (257)
Patient recruitment (118)
Peanut (50)
People (60043)
Pharmaceutical (132)
Pharmacy benefit managers (21)
Phase I (20901)
Phase II (29672)
Phase III (22308)
Pipeline (1413)
Policy (170)
Postmarket research (2502)
Preclinical (8795)
Press Release (68)
Prostate cancer (111)
Psychedelics (37)
Radiopharmaceuticals (265)
Rare diseases (411)
Real estate (6235)
Recruiting (71)
Regulatory (22904)
Reports (41)
Research institute (2116)
Resumes & cover letters (439)
Rett syndrome (6)
RNA editing (5)
RSV (47)
Schizophrenia (82)
Series A (142)
Series B (98)
Service/supplier (27)
Sickle cell disease (56)
Special edition (19)
Spinal muscular atrophy (153)
Sponsored (29)
Startups (3975)
State (2)
Stomach cancer (16)
Supply chain (74)
Tariffs (58)
The Weekly (70)
Vaccines (767)
Venture capitalists (45)
Weight loss (278)
Women's health (33)
Worklife (20)
Date
Today (128)
Last 7 days (998)
Last 30 days (3365)
Last 365 days (33909)
2025 (12511)
2024 (36801)
2023 (41532)
2022 (52262)
2021 (56411)
2020 (54607)
2019 (47212)
2018 (35971)
2017 (34343)
2016 (33763)
2015 (39425)
2014 (32882)
2013 (28113)
2012 (29395)
2011 (29549)
2010 (27604)
Location
Africa (899)
Alabama (60)
Alaska (7)
Arizona (199)
Arkansas (12)
Asia (43146)
Australia (7174)
California (6653)
Canada (2095)
China (568)
Colorado (285)
Connecticut (303)
Delaware (167)
Europe (96076)
Florida (954)
Georgia (224)
Hawaii (1)
Idaho (58)
Illinois (570)
India (30)
Indiana (340)
Iowa (12)
Japan (178)
Kansas (104)
Kentucky (25)
Louisiana (14)
Maine (68)
Maryland (898)
Massachusetts (5083)
Michigan (244)
Minnesota (421)
Mississippi (2)
Missouri (88)
Montana (31)
Nebraska (23)
Nevada (65)
New Hampshire (67)
New Jersey (1874)
New Mexico (30)
New York (1853)
North Carolina (1117)
North Dakota (8)
Northern California (2890)
Ohio (220)
Oklahoma (15)
Oregon (44)
Pennsylvania (1453)
Puerto Rico (14)
Rhode Island (36)
South America (1289)
South Carolina (26)
South Dakota (1)
Southern California (2452)
Tennessee (104)
Texas (965)
United States (24986)
Utah (193)
Virginia (167)
Washington D.C. (67)
Washington State (602)
West Virginia (3)
Wisconsin (66)
718,884 Results for "yoh a day and zimmermann company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ligand Appoints Martine Zimmermann to its Board of Directors
Ligand Pharmaceuticals Incorporated announced the appointment of Martine Zimmermann, PharmD, to its Board of Directors as an independent director.
September 26, 2023
·
3 min read
Biotech Beach
Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs
Gossamer Bio, Inc. announced that Rainer Zimmermann, MD, has joined the Company as Vice President of Medical Affairs.
October 3, 2023
·
5 min read
Press Releases
Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders
April 30, 2025
·
8 min read
Government
Drugmakers Ask Trump for Staggered Tariffs as ‘Liberation Day’ Arrives
Trump has repeatedly called April 2 “Liberation Day,” alluding to a more sweeping and aggressive set of tariffs. Leerink Partners analysts said that the risks from Trump’s tariffs on the biopharma industry are “underappreciated.”
April 2, 2025
·
2 min read
·
Tristan Manalac
Duchenne muscular dystrophy
Committee Recommends EU Trials of Sarepta’s Elevidys Continue, Day After Holds
One day after the European Medicines Agency requested that three clinical trials of Elevidys be placed on hold after the death of a U.S. teenager, a data monitoring committee concluded that they should continue unchanged.
April 4, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Day One Reports First Quarter 2025 Financial Results and Corporate Progress
May 7, 2025
·
10 min read
Press Releases
ImmunityBio to Host Investor Day
March 26, 2025
·
6 min read
Press Releases
Serina Therapeutics to Present at JonesResearch Virtual CNS Day
April 29, 2025
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Press Releases
Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
May 7, 2025
·
2 min read
1 of 71,889
Next
